Biological Products, (No Diagnostic Substances)
| Institution | Shares | Value | Ownership % | Change | Filing Date |
|---|---|---|---|---|---|
| MPM BIOIMPACT LLC | 9.73M | $177.0M | 15.12% | +2.08M | 2026-06-30 |
| Lynx1 Capital Management LP | 8.96M | $163.0M | 13.93% | -- | 2026-06-30 |
| BVF INC/IL | 5.75M | $104.0M | 8.94% | -- | 2026-06-30 |
| BlackRock, Inc. | 5.23M | $95.0M | 8.13% | +782.8K | 2026-06-30 |
| PRICE T ROWE ASSOCIATES INC /MD/ | 3.83M | $69.0M | 5.95% | +1.80M | 2026-06-30 |
| STATE STREET CORP | 3.67M | $66.0M | 5.70% | +1.12M | 2026-06-30 |
| Kynam Capital Management, LP | 3.11M | $56.0M | 4.84% | -- | 2026-06-30 |
| VANGUARD CAPITAL MANAGEMENT LLC | 2.61M | $47.0M | 4.06% | +131.0K | 2026-06-30 |
| RTW INVESTMENTS, LP | 2.36M | $43.0M | 3.67% | +658.4K | 2026-06-30 |
| Siren, L.L.C. | 1.89M | $34.0M | 2.94% | +700.0K | 2026-06-30 |
